
| Traded as | NYSE: NVS |
|---|---|
| Industry | Drug Manufacturers – Major |
| Founded | 1996 |
| Headquarters | Basel 4056, Switzerland |
|
CEO
|
Mr. Joseph Jimenez |
| Revenue | US$ 50.387 billion |
|
Operating income
|
US$ 8.977 billion |
|
Net income
|
US$ 17.794 billion |
| Total assets | US$ 131.556 billion |
| Total equity | US$ 77.046 billion |
|
Number of employees
|
118.000 |
| Website | Novartis.com |
|
Source
|
Novartis.com |
About:
Novartis AG,
is a biotechnology and pharmaceutical company based in Basel, Switzerland. The company was created in 1996 from the merger of “Ciba-Geigy AG” and “Sandoz”. Novartis goes back to several Basler tar-colour producers who joined together over the time to Novartis. Today, Novartis is the world’s largest pharmaceutical company and has, under the current CEO Joseph Jimenez, 118000 employees and a revenue of 50.387 billion USD.
Operation divisions: Pharmaceuticals (Consumer health and animal health)
Since 1996, Novartis has engaged in a number of M&A deals: 106 transactions with a value of USD 107.83 bil. (for number and value per year, see figure below).
M&A Novartis
Top 10 Deals Novartis
| Rank | Date | Target | Nation | Value (in bil. USD) | Status |
|---|---|---|---|---|---|
| 1 | 04.07.2008 | Alcon Inc | Switzerland | 27.73 | Completed |
| 2 | 04.22.2014 | GlaxoSmithKline PLC Oncology | United Kingdom | 16.00 | Completed |
| 3 | 01.04.2010 | Alcon Inc | Switzerland | 12.14 | Completed |
| 4 | 04.07.2008 | Alcon Inc | Switzerland | 10.55 | Completed |
| 5 | 09.01.2005 | Chiron Corp | United States | 6.21 | Completed |
| 6 | 02.21.2005 | Hexal AG | Germany | 5.68 | Completed |
| 7 | 12.02.1999 | AstraZeneca PLC Agrochemicals | Switzerland | 5.06 | Completed |
| 8 | 05.07.2001 | Roche Holding AG | Switzerland | 2.79 | Completed |
| 9 | 12.31.2002 | Roche Holding AG | Switzerland | 2.58 | Completed |
| 10 | 01.21.1998 | Allied Colloids Group PLC | United Kingdom | 2.31 | Completed |